Reviva Pharmaceuticals
RVPH
RVPH
31 hedge funds and large institutions have $8.75M invested in Reviva Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.01% more ownership
Funds ownership: 19.96% → 22.97% (+3%)
58% less capital invested
Capital invested by funds: $21M → $8.75M (-$12.3M)
Holders
31
Holding in Top 10
1
Calls
$492K
Puts
$176K
Top Buyers
| 1 | +$688K | |
| 2 | +$495K | |
| 3 | +$303K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$240K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$159K |
Top Sellers
| 1 | -$258K | |
| 2 | -$146K | |
| 3 | -$132K | |
| 4 |
Jane Street
New York
|
-$114K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
-$52.9K |